Visualising SARS-CoV-2 transmission routes and mitigations
BMJ 2021; 375 doi: https://doi.org/10.1136/bmj-2021-065312 (Published 01 December 2021) Cite this as: BMJ 2021;375:e065312Linked BMJ Open research
Expert elicitation on the relative importance of possible SARS-CoV-2 transmission routes and the effectiveness of mitigations
Linked Opinion
The eyes have it: getting the gist of covid-19 transmission
All rapid responses
Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web address) of an individual response, simply click on the response headline and copy the URL from the browser window. A proportion of responses will, after editing, be published online and in the print journal as letters, which are indexed in PubMed. Rapid responses are not indexed in PubMed and they are not journal articles. The BMJ reserves the right to remove responses which are being wilfully misrepresented as published articles or when it is brought to our attention that a response spreads misinformation.
From March 2022, the word limit for rapid responses will be 600 words not including references and author details. We will no longer post responses that exceed this limit.
The word limit for letters selected from posted responses remains 300 words.
Dear Editor
The paper "Visualising expert estimates of covid-19 transmission" has collected expert evidence on COVID-19 transmission and used this to develop an interactive visualisation of risk of transmission.
The data was collected from 26 experts, but we are not told how the data (e.g., validity and confidence intervals) are represented, nor are we told how the data is processed to generate the results presented in the visualisation.
The visualisation represents its risk calculations by coloured values over the descriptive range "lo" to "high", described as "colours show how much infectious virus is likely to be passed on" but with no indication of the practical interpretation of any such value. However, data used by the program uses ratings from 0% (no protection) to 100% (total protection), but it is not explained how these values map to the colour range.
The core of the visualisation is a JavaScript program about 2000 lines long (plus some standard libraries). The code reads in about 7000 cells of CSV numerical and textual data from several files. Although there is console logging (probably for debugging), there is no data validation. Since there are approximately 5000 empty data cells in the CSV tables, the absence of validation is worrying for what appears to be a manually or partly-manually created database. (There is a field "Length of time" in the data but it is not used in the visualisation.) One CSV file defines the infection graph that, at least as defined, has cycles which would make calculating risk complex. The code has many hard-wired values, for instance some refer to specific numbered cells in the CSV data. This and many other obscure programming practices are visible throughout. (As neither the data nor code are documented, this quick summary may have errors due to my misunderstanding of the system.)
In short: while the authors are to be congratulated on collecting the data from experts, and for presenting their results of the paper in an attractive interactive visualisation that integrates the expert opinions, the actual data, results and methods are obscure. The paper and the visualisation tool do not support independent scrutiny. In particular, the ad hoc nature of the code and data (and that code and data would have been effectively impossible to review) mean the visualisation must be used with caution.
In my view, the visualisation tool (at least in its current form) unfortunately cannot be used for any safety critical application.
Yours,
Harold Thimbleby
Competing interests: No competing interests
Re: Visualising SARS-CoV-2 transmission routes and mitigations
Dear Editor,
The tool is fantastic and really interesting, visualizing in a simple and interactive way the transmission routes.
I have only one observation: if I'm not wrong the scenario of vaccination (1-2 + booster) is not contemplated. I think would be very educative to add it.
Kind regards
Competing interests: No competing interests